{"count": 31, "results": [{"_id": "35802672", "pmid": 35802672, "pmcid": "PMC9269956", "title": "Metformin suppresses pro-inflammatory cytokines in vitreous of diabetes patients and human retinal vascular endothelium", "journal": "PLoS One", "authors": ["Li Y", "Gappy S", "Liu X", "Sassalos T", "Zhou T", "Hsu A", "Zhang A", "Edwards PA", "Gao H", "Qiao X"], "date": "2022-07-08T00:00:00Z", "doi": "10.1371/journal.pone.0268451", "meta_date_publication": "2022", "meta_volume": "17", "meta_issue": "7", "meta_pages": "e0268451", "score": 50281.04, "text_hl": "This study aims to test the hypothesis that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ suppresses @<m>DISEASE_Diabetic_Retinopathy</m> @DISEASE_MESH:D003930 @@@diabetic retinopathy@@@ (@<m>DISEASE_Diabetic_Retinopathy</m> @DISEASE_MESH:D003930 @@@DR@@@) associated @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@intraocular inflammation@@@. ", "citations": {"NLM": "Li Y, Gappy S, Liu X, Sassalos T, Zhou T, Hsu A, Zhang A, Edwards PA, Gao H, Qiao X. Metformin suppresses pro-inflammatory cytokines in vitreous of diabetes patients and human retinal vascular endothelium PLoS One. 2022;17(7):e0268451. PMID: 35802672", "BibTeX": "@article{35802672, title={Metformin suppresses pro-inflammatory cytokines in vitreous of diabetes patients and human retinal vascular endothelium}, author={Li Y and Gappy S and Liu X and Sassalos T and Zhou T and Hsu A and Zhang A and Edwards PA and Gao H and Qiao X}, journal={PLoS One}, volume={17}, number={7}, pages={e0268451}}"}}, {"_id": "32377525", "pmid": 32377525, "pmcid": "PMC7189314", "title": "Metformin Treatment Is Associated with a Decreased Risk of Nonproliferative Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus: A Population-Based Cohort Study", "journal": "J Diabetes Res", "authors": ["Fan YP", "Wu CT", "Lin JL", "Hsiung CA", "Liu HY", "Lai JN", "Yang CC"], "date": "2020-04-19T00:00:00Z", "doi": "10.1155/2020/9161039", "meta_date_publication": "2020", "meta_volume": "2020", "meta_issue": "", "meta_pages": "9161039", "score": 50278.754, "text_hl": "Animal studies also indicated @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@'s protective effects against @<m>DISEASE_Diabetic_Retinopathy</m> @DISEASE_MESH:D003930 @@@DR@@@. ", "citations": {"NLM": "Fan YP, Wu CT, Lin JL, Hsiung CA, Liu HY, Lai JN, Yang CC. Metformin Treatment Is Associated with a Decreased Risk of Nonproliferative Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus: A Population-Based Cohort Study J Diabetes Res. 2020;2020():9161039. PMID: 32377525", "BibTeX": "@article{32377525, title={Metformin Treatment Is Associated with a Decreased Risk of Nonproliferative Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus: A Population-Based Cohort Study}, author={Fan YP and Wu CT and Lin JL and Hsiung CA and Liu HY and Lai JN and Yang CC}, journal={J Diabetes Res}, volume={2020}, pages={9161039}}"}}, {"_id": "34096218", "pmid": 34096218, "pmcid": "PMC8181317", "title": "Metformin Reduces Vascular Assembly in High Glucose-Treated Human Microvascular Endothelial Cells in An AMPK-Independent Manner", "journal": "Cell J", "authors": ["Silva C", "Rodrigues I", "Andrade S", "Costa R", "Soares R"], "date": "2021-07-01T00:00:00Z", "doi": "10.22074/cellj.2021.7212", "meta_date_publication": "2021 Jul", "meta_volume": "23", "meta_issue": "2", "meta_pages": "174-183", "score": 50273.066, "text_hl": "The present study shows that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ not only regulates metabolism, but also probably controls endothelial dysfunction, being important in preventing conditions where angiogenesis is exacerbated such as @<m>DISEASE_Diabetic_Retinopathy</m> @DISEASE_MESH:D003930 @@@diabetic retinopathy@@@ or @DISEASE_Kidney_Diseases @DISEASE_MESH:D007674 @@@nephropathy@@@. ", "citations": {"NLM": "Silva C, Rodrigues I, Andrade S, Costa R, Soares R. Metformin Reduces Vascular Assembly in High Glucose-Treated Human Microvascular Endothelial Cells in An AMPK-Independent Manner Cell J. 2021 Jul;23(2):174-183. PMID: 34096218", "BibTeX": "@article{34096218, title={Metformin Reduces Vascular Assembly in High Glucose-Treated Human Microvascular Endothelial Cells in An AMPK-Independent Manner}, author={Silva C and Rodrigues I and Andrade S and Costa R and Soares R}, journal={Cell J}, volume={23}, number={2}, pages={174-183}}"}}, {"_id": "37816862", "pmid": 37816862, "pmcid": "PMC10564914", "title": "Sodium-glucose co-transporter 2 inhibitor add-on therapy for metformin delays diabetic retinopathy progression in diabetes patients: a population-based cohort study", "journal": "Sci Rep", "authors": ["Li JX", "Hung YT", "Bair H", "Hsu SB", "Hsu CY", "Lin CJ"], "date": "2023-10-10T00:00:00Z", "doi": "10.1038/s41598-023-43893-2", "meta_date_publication": "2023 Oct 10", "meta_volume": "13", "meta_issue": "1", "meta_pages": "17049", "score": 50270.35, "text_hl": "Co-administration of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and SGLT2is may reduce the risk of @<m>DISEASE_Diabetic_Retinopathy</m> @DISEASE_MESH:D003930 @@@DR@@@ progression. ", "citations": {"NLM": "Li JX, Hung YT, Bair H, Hsu SB, Hsu CY, Lin CJ. Sodium-glucose co-transporter 2 inhibitor add-on therapy for metformin delays diabetic retinopathy progression in diabetes patients: a population-based cohort study Sci Rep. 2023 Oct 10;13(1):17049. PMID: 37816862", "BibTeX": "@article{37816862, title={Sodium-glucose co-transporter 2 inhibitor add-on therapy for metformin delays diabetic retinopathy progression in diabetes patients: a population-based cohort study}, author={Li JX and Hung YT and Bair H and Hsu SB and Hsu CY and Lin CJ}, journal={Sci Rep}, volume={13}, number={1}, pages={17049}}"}}, {"_id": "33203090", "pmid": 33203090, "pmcid": "PMC7696108", "title": "Inhibitory Action of Antidiabetic Drugs on the Free Radical Production by the Rod Outer Segment Ectopic Aerobic Metabolism", "journal": "Antioxidants (Basel)", "authors": ["Ravera S", "Caicci F", "Degan P", "Maggi D", "Manni L", "Puddu A", "Nicolò M", "Traverso CE", "Panfoli I"], "date": "2020-11-15T00:00:00Z", "doi": "10.3390/antiox9111133", "meta_date_publication": "2020 Nov 15", "meta_volume": "9", "meta_issue": "11", "meta_pages": "", "score": 50263.49, "text_hl": "Long-term use of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ was independently associated with a significantly lower rate of severe non-proliferative or proliferative @<m>DISEASE_Diabetic_Retinopathy</m> @DISEASE_MESH:D003930 @@@DR@@@ and significantly lower risk of development of @DISEASE_Macular_Degeneration @DISEASE_MESH:D008268 @@@AMD@@@. ", "citations": {"NLM": "Ravera S, Caicci F, Degan P, Maggi D, Manni L, Puddu A, Nicolò M, Traverso CE, Panfoli I. Inhibitory Action of Antidiabetic Drugs on the Free Radical Production by the Rod Outer Segment Ectopic Aerobic Metabolism Antioxidants (Basel). 2020 Nov 15;9(11):. PMID: 33203090", "BibTeX": "@article{33203090, title={Inhibitory Action of Antidiabetic Drugs on the Free Radical Production by the Rod Outer Segment Ectopic Aerobic Metabolism}, author={Ravera S and Caicci F and Degan P and Maggi D and Manni L and Puddu A and Nicolò M and Traverso CE and Panfoli I}, journal={Antioxidants (Basel)}, volume={9}, number={11}}"}}, {"_id": "35068220", "pmid": 35068220, "title": "Metformin and retinal diseases in preclinical and clinical studies: Insights and review of literature.", "journal": "Exp Biol Med (Maywood)", "authors": ["Amin SV", "Khanna S", "Parvar SP", "Shaw LT", "Dao D", "Hariprasad SM", "Skondra D"], "date": "2022-02-01T00:00:00Z", "doi": "10.1177/15353702211069986", "meta_date_publication": "2022 Feb", "meta_volume": "247", "meta_issue": "4", "meta_pages": "317-329", "score": 50259.62, "text_hl": "We then explore the sparse but promising retrospective clinical data on @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@'s potential protective role in @<m>DISEASE_Diabetic_Retinopathy</m> @DISEASE_MESH:D003930 @@@DR@@@, @DISEASE_Macular_Degeneration @DISEASE_MESH:D008268 @@@AMD@@@, @DISEASE_Glaucoma_Open_Angle @DISEASE_MESH:D005902 @@@POAG@@@, and @DISEASE_Uveitis @DISEASE_MESH:D014605 @@@uveitis@@@. ", "citations": {"NLM": "Amin SV, Khanna S, Parvar SP, Shaw LT, Dao D, Hariprasad SM, Skondra D. Metformin and retinal diseases in preclinical and clinical studies: Insights and review of literature. Exp Biol Med (Maywood). 2022 Feb;247(4):317-329. PMID: 35068220", "BibTeX": "@article{35068220, title={Metformin and retinal diseases in preclinical and clinical studies: Insights and review of literature.}, author={Amin SV and Khanna S and Parvar SP and Shaw LT and Dao D and Hariprasad SM and Skondra D}, journal={Exp Biol Med (Maywood)}, volume={247}, number={4}, pages={317-329}}"}}, {"_id": "35684409", "pmid": 35684409, "pmcid": "PMC9182214", "title": "A Drug-Drug Multicomponent Crystal of Metformin and Dobesilate: Crystal Structure Analysis and Hygroscopicity Property", "journal": "Molecules", "authors": ["Jiang L", "Hu X", "Cai L"], "date": "2022-05-27T00:00:00Z", "doi": "10.3390/molecules27113472", "meta_date_publication": "2022 May 27", "meta_volume": "27", "meta_issue": "11", "meta_pages": "", "score": 50259.38, "text_hl": "A drug-drug multicomponent crystal consisting of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MET@@@) and dobesilate (DBS) was prospectively connected by solvent cooling and evaporating co-crystallization using the multicomponent crystal strategy, not only to optimize the physicochemical properties of single drugs, but also to play a role in the cooperative effect of DBS with the potential vascular protective effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MET@@@ against @<m>DISEASE_Diabetic_Retinopathy</m> @DISEASE_MESH:D003930 @@@diabetic retinopathy@@@ (@<m>DISEASE_Diabetic_Retinopathy</m> @DISEASE_MESH:D003930 @@@DR@@@). ", "citations": {"NLM": "Jiang L, Hu X, Cai L. A Drug-Drug Multicomponent Crystal of Metformin and Dobesilate: Crystal Structure Analysis and Hygroscopicity Property Molecules. 2022 May 27;27(11):. PMID: 35684409", "BibTeX": "@article{35684409, title={A Drug-Drug Multicomponent Crystal of Metformin and Dobesilate: Crystal Structure Analysis and Hygroscopicity Property}, author={Jiang L and Hu X and Cai L}, journal={Molecules}, volume={27}, number={11}}"}}, {"_id": "38408173", "pmid": 38408173, "title": "Association of metformin use with risk of newly onset neovascular age-related macular degeneration development.", "journal": "Retina", "authors": ["Khanna S", "Shaw L", "Hyman MJ", "Zhang J", "Hariprasad S", "Soo J", "Flores A", "Skondra D"], "date": "2023-10-30T00:00:00Z", "doi": "10.1097/IAE.0000000000003968", "meta_date_publication": "2023 Oct 30", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50259.004, "text_hl": "CONCLUSIONS: @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ use was associated with reduced OR of @DISEASE_Glycogen_Storage_Disease_Type_II @DISEASE_MESH:D006009 @@@nAMD@@@, particularly in @SPECIES_9606 @@@patients@@@ without @<m>DISEASE_Diabetic_Retinopathy</m> @DISEASE_MESH:D003930 @@@DR@@@. ", "citations": {"NLM": "Khanna S, Shaw L, Hyman MJ, Zhang J, Hariprasad S, Soo J, Flores A, Skondra D. Association of metformin use with risk of newly onset neovascular age-related macular degeneration development. Retina. 2023 Oct 30;():. PMID: 38408173", "BibTeX": "@article{38408173, title={Association of metformin use with risk of newly onset neovascular age-related macular degeneration development.}, author={Khanna S and Shaw L and Hyman MJ and Zhang J and Hariprasad S and Soo J and Flores A and Skondra D}, journal={Retina}}"}}, {"_id": "32572457", "pmid": 32572457, "pmcid": "PMC7415324", "title": "Metformin Corrects Abnormal Circadian Rhythm and Kir4.1 Channels in Diabetes", "journal": "Invest Ophthalmol Vis Sci", "authors": ["Alex A", "Luo Q", "Mathew D", "Di R", "Bhatwadekar AD"], "date": "2020-06-03T00:00:00Z", "doi": "10.1167/iovs.61.6.46", "meta_date_publication": "2020 Jun 3", "meta_volume": "61", "meta_issue": "6", "meta_pages": "46", "score": 50258.12, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ could represent a critical pharmacological agent for preventing Muller cell @DISEASE_Heart_Diseases @DISEASE_MESH:D006331 @@@dysfunction@@@ observed in @SPECIES_9606 @@@human@@@ @<m>DISEASE_Diabetic_Retinopathy</m> @DISEASE_MESH:D003930 @@@DR@@@.", "citations": {"NLM": "Alex A, Luo Q, Mathew D, Di R, Bhatwadekar AD. Metformin Corrects Abnormal Circadian Rhythm and Kir4.1 Channels in Diabetes Invest Ophthalmol Vis Sci. 2020 Jun 3;61(6):46. PMID: 32572457", "BibTeX": "@article{32572457, title={Metformin Corrects Abnormal Circadian Rhythm and Kir4.1 Channels in Diabetes}, author={Alex A and Luo Q and Mathew D and Di R and Bhatwadekar AD}, journal={Invest Ophthalmol Vis Sci}, volume={61}, number={6}, pages={46}}"}}, {"_id": "39891223", "pmid": 39891223, "title": "Impact of duration of treatments with metformin and sulfonylureas, individually or in combination, on diabetic retinopathy among newly diagnosed type 2 diabetic patients: a pooled cohort's analysis.", "journal": "Int J Retina Vitreous", "authors": ["Bahardoust M", "Mehrabi Y", "Hadaegh F", "Khalili D", "Delpisheh A"], "date": "2025-01-31T00:00:00Z", "doi": "10.1186/s40942-025-00637-w", "meta_date_publication": "2025 Jan 31", "meta_volume": "11", "meta_issue": "1", "meta_pages": "9", "score": 50257.004, "text_hl": "This study aimed to evaluate the effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and SUs' medication time on @<m>DISEASE_Diabetic_Retinopathy</m> @DISEASE_MESH:D003930 @@@DR@@@ among newly diagnosed T2DM using a pooled analysis. ", "citations": {"NLM": "Bahardoust M, Mehrabi Y, Hadaegh F, Khalili D, Delpisheh A. Impact of duration of treatments with metformin and sulfonylureas, individually or in combination, on diabetic retinopathy among newly diagnosed type 2 diabetic patients: a pooled cohort's analysis. Int J Retina Vitreous. 2025 Jan 31;11(1):9. PMID: 39891223", "BibTeX": "@article{39891223, title={Impact of duration of treatments with metformin and sulfonylureas, individually or in combination, on diabetic retinopathy among newly diagnosed type 2 diabetic patients: a pooled cohort's analysis.}, author={Bahardoust M and Mehrabi Y and Hadaegh F and Khalili D and Delpisheh A}, journal={Int J Retina Vitreous}, volume={11}, number={1}, pages={9}}"}}]}